Exceptional Responder to Immunotherapy: A Rare Case of Post- HSCT DLBCL Relapse Responding to Nivolumab

Irappa Madabhavi, Sandeep KS, Malay Sarkar, Mitul Modi

Open source

DOI: 10.18502/ijhoscr.v13i2.691
Published: 2019-04-27
Container: International Journal of Hematology-Oncology and Stem Cell Research
Publisher: Knowledge E DMCC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.18502/ijhoscr.v13i2.691,
  title = {Exceptional Responder to Immunotherapy: A Rare Case of Post- HSCT DLBCL Relapse Responding to Nivolumab},
  author = {Irappa Madabhavi and Sandeep KS and Malay Sarkar and Mitul Modi},
  year = {2019},
  journal = {International Journal of Hematology-Oncology and Stem Cell Research},
  doi = {10.18502/ijhoscr.v13i2.691},
  url = {https://doi.org/10.18502/ijhoscr.v13i2.691}
}

RIS

TY  - JOUR
TI  - Exceptional Responder to Immunotherapy: A Rare Case of Post- HSCT DLBCL Relapse Responding to Nivolumab
AU  - Irappa Madabhavi
AU  - Sandeep KS
AU  - Malay Sarkar
AU  - Mitul Modi
PY  - 2019
JO  - International Journal of Hematology-Oncology and Stem Cell Research
DO  - 10.18502/ijhoscr.v13i2.691
UR  - https://doi.org/10.18502/ijhoscr.v13i2.691
ER  -

APA

Madabhavi, I., KS, S., Sarkar, M., & Modi, M. (2019). Exceptional Responder to Immunotherapy: A Rare Case of Post- HSCT DLBCL Relapse Responding to Nivolumab. International Journal of Hematology-Oncology and Stem Cell Research. https://doi.org/10.18502/ijhoscr.v13i2.691

Source records

crossref · retrieved 2026-09-26T12:55:52.686Z